chapter 21 venous & lymphatic
TRANSCRIPT
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 1/29
CHAPTER 21 - Venous and Lymphatic Disease
Richard M. Green
Kenneth Ouriel
VENOU D!EAE
Venous Anatomy and Physio"o#y
Lower extremity veins can be divided into three types: superficial, deep, and
perforatin veins !"i. #$%$&. 'he systemic veins contain approximately two%thirds of
the circulatin blood volume under relatively low pressure, and venous flow from the
lower extremities must overcome ravity and intraabdominal pressure to return blood
to the riht ventricle. 'he initial force produced by the left ventricle is reduced
throuh the capillary bed to a pressure of about $( mm) in the venules. 'he calf
muscles provide an additional pump function as they compress deep veins within an
unyieldin fascial compartment. *roximal flow is assured by the presence of the
delicate but stron venous valves, which prevent reflux.
The supe$%icia" &enous system is composed of the reater and lesser saphenous veins
!G+ and L+& and lies above the investin fascia. 'he G+ beins in the dorsum of
the foot and ascends cephalad anterior to the medial malleolus. -t runs alon the
medial aspect of the le, crossin the nee /oint 0 to $1 cm dorsal to the medial ede
of the patella. 'he saphenous nerve accompanies the vein from the foot to the upper
thih, where it penetrates the fascia and enters the subsartorial canal alon the
superficial femoral artery. 'he G+ pierces +carpa2s fascia in the midthih and enters
the fossa ovalis in the roin, 3 cm lateral and inferior to the pubic tubercle. 'he L+
beins laterally from the dorsal venous arch, courses posterior to the lateral malleolus,
and enters the popliteal vein between the medial and lateral heads of the
astrocnemius muscle. 'he sural nerve lies lateral to the G+.
The deep &eins are primarily responsible for lower extremity venous return. 'hese
veins follow the course of the ma/or arteries and share their names. -n the lower le
the veins are paired and /oin at the nee to form the popliteal vein, which continues
throuh the adductor hiatus to become the superficial femoral vein. 'he latter is
/oined by the deep femoral vein in the upper thih to become the common femoral
vein, which becomes the external iliac vein as it enters the pelvis beneath the inuinal
liament. 4umbers of valves increase with distance from the heart, thouh the vena
cava and common iliac veins are valveless. 5ach valve is based within a dilated sinusof the vein, which eeps the valve cusps away from the walls and promotes rapid
closure when flow ceases. alves are the focal point of most of the patholoy of
venous thrombosis because their sinuses are where the initial thrombus forms, and the
loss of valvular function after recanali6ation of a thrombus produces venous
insufficiency !"i. #$%#&. 7utopsies suest that it is more common for thrombi to
oriinate in the veins of the soleus and then propaate proximally, but there is
evidence that primary thrombosis of the femoral and iliac venous tributaries occurs as
well. 'here also are a number of venous sinuses within the substance of the soleus
muscle, which empty into the posterior tibial vein, and in the astrocnemius muscle,
which empty into the popliteal vein. 'hese sinuses are critical to the function of the
calf muscle pump.
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 2/29
'he perforatin or communicatin veins connect the superficial venous system with
the deep and direct flow internally from the superficial veins in all areas of the lower
extremity except the foot, where the opposite occurs. 'he perforatin veins are so
named because they penetrate the fascia of the lower le to connect the superficial and
deep systems. 'he perforators ad/acent to the medial malleolus often are responsible
for the development of stasis ulcers at that level when they become incompetent.8oyd2s perforator connects the G+ to the deep veins $1 cm below the nee.
9ocett2s perforators connect the posterior arch vein with the posterior tibial vein and
often become varicose. 'he )unterian perforator connects the G+ to the superficial
femoral vein its incompetence accounts for many thih varicosities when the
saphenofemoral /unction is competent.
;hen a person is in the supine position, lower extremity venous return is primarily
dependent on the respiratory cycle. -ntraabdominal pressure increases as the
diaphram descends durin inspiration and the external pressure on the external iliac
veins decreases venous return. alve closure prevents sinificant reflux durin
inspiration. 'he converse occurs durin expiration. enous return is increased asintraabdominal pressure is decreased with upward movement of the diaphram. ;hen
a person is in the upriht position, venous flow is dependent on the contractile force
of the heart, static fillin pressure, and ravity. 'he expiratory enhancement of venous
flow is insufficient, and the calf muscle pump is necessary to overcome the
hydrostatic forces. 7 sinle contraction of the calf muscles can empty <1 percent of
the blood pooled in the tibial veins and muscular sinuses. 'he standin venous
pressure in the foot veins is 01 to =1 mm) while standin and falls to 31 mm)
durin ambulation !see "i. #$%##&.
Deep Vein Th$om'osis
Etio"o#y of >eep ein 'hrombosis
'hree factors are primarily responsible for the development of a thrombus within a
vein: abnormalities of blood flow, abnormalities of blood, and in/ury to the vessel
wall. 'he occurrence of this process in a nontraumati6ed vein was reconi6ed by
Rudolf irchow, who introduced the term thrombosis in $0(<.
tasis
7lthouh stasis alone is not sufficient, it is the most important factor in the
development of deep vein thrombosis !>'&. 'he main event in the formation of a
venous thrombus is the eneration of thrombin in areas of stasis. 'his leads to plateletareation and fibrin formation. ;hen contrast medium is in/ected into the veins of
the lower extremities of a bedridden patient, it may remain in venous valve sinuses for
as lon as an hour, confirmin the poolin effect in the soleal veins. *rimary and
secondary vortices are produced beyond the valve cusps, the favored location for the
formation of a thrombus, and trap red cells to form the early nidus for thrombus
formation. 5arly thrombi attach to normal endothelium and consist of loosely paced
red cells within a fibrin networ accompanied by a variable number of leuocytes.
'he propaation of the thrombus depends on the relative balance between activated
coaulation and fibrinolysis. More commonly, in about <1 percent of patients the
thrombus propaates without interruptin flow and develops a lon floatin ?tail@ that
is more susceptible to breain loose from its tenuous anchor within the valvularsinus. -t is the latter seAuence of events that is the most danerous aspect of the
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 3/29
disorder, because ma/or pulmonary embolism can and does occur without
premonitory sins or symptoms at its point of oriin. 'his process can bein under
eneral anesthesia in the operatin room but usually reAuires other contributin
factors such as shoc, infection, trauma, or conestive heart failure. 7in, obesity,
prenancy, and malinant disease also are important ris factors.
Endothe"ia" Dama#e
'he role of endothelial in/ury is Auestionable. -t appears that it is neither a necessary
nor a sufficient condition for thrombosis. ;ith the exceptions of hip arthroplasty and
central venous catheters, there is little evidence that ross or microscopic venous
in/ury has a role in venous thromboenesis. Routine histoloic examination of veins
containin thrombus usually fails to show an inflammatory response consistent with
vessel wall in/ury. -t is possible that hypoxic or biochemical in/ury has a role, but
definitive evidence is lacin.
Hype$coa#u"a'i"ity
7bnormalities of the blood include aberrations of the clottin and fibrinolyticsystems. +tasis and in/ury alone are not sufficient to cause thrombosis experimentally
in the absence of low levels of activated coaulation factors. *atients who present at
an early ae with spontaneous venous thrombosis, who have a stron family history of
>', or who develop recurrent venous thromboembolisms are usually considered
?prothrombotic@ or ?hypercoaulable.@ 'hese conditions are listed in 'able #$%$.
7ctivated protein 9 resistance !7*9%R& is a common hereditary condition that results
in decreased efficacy of the natural anticoaulant protein 9. -t is transmitted as an
autosomal dominant trait, and =1 percent of the cases are because of a mutation in
factor !factor Leiden mutation&. 'he syndrome was initially described in youn
patients with venous thrombosis but may also have a role in hypercoaulability after
arterial reconstruction.
7ntithrombin --- deficiency often is associated with unexplained arterial thrombosis.
-t is found more often in patients with serum albumin levels less than B.1 CdL.
*atients with antithrombin --- deficiency present as a resistance to heparin. 'ypically,
heparin is iven and no increase in the partial thromboplastin time !*''& is noted. -n
this settin, immediate anticoaulation can be achieved by providin substrate !fresh
fro6en plasma& in addition to heparin and then conversion to coumarin derivatives.
'he antiphospholipid syndrome !7*+& is another hypercoaulable state with recurrent
thrombotic events and antibodies directed aainst phospholipids. 'here are primary
!no associated autoimmune disease& and secondary forms. 7*+ occurs in youner
patients rather than in atherosclerotic populations, and very few of these patients
smoe. 7ntiphospholipid antibodies, which include anticardiolipin, are bein
reconi6ed with increasin freAuency in association with a variety of thrombotic
disorders. 'heir association with unexplained /uvenile >' indicates that screenin
for antiphospholipid antibodies should be included in the worup of any unexplained
thrombosis. One% third of patients with systemic lupus erythematosus have
antiphospholipid antibodies. ;omen with 7*+ often have a history of spontaneous
abortions. 'he dianosis is suested in a patient with an appropriate history and aspurious elevation of the *''. *atients on estroen therapy for postmenopausal
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 4/29
replacement, birth control, or chemotherapy are at increased ris for venous
thrombosis.
'he association between venous thrombosis and cancer was first suested by
7rmand 'rousseau in $0(< and often has been confirmed in postmortem studies. -n a
series reported by 7dera and associates, B3 percent of otherwise healthy patientswith idiopathic >' were found to have malinant disease dianosed an averae of
#3 months later. -ncreased lielihood of cancer in these patients was associated with
ae over <( years, anemia, and eosinophilia. 'he earliest%onset malinancies were
found within $ year and usually occurred in the pelvic orans and breast.
*atients presentin with a thrombotic episode at a youn ae or those with previous
events should be screened for hypercoaulability. Routine screenin should include
measurements of prothrombin time, activated partial thromboplastin time, hematocrit
level, white blood cell count, sedimentation rate, and platelet count. Measurements of
homocysteine levels, antiphospholipid antibodies, protein 9 and protein +,
antithrombin ---, activated protein 9 resistance, platelet areation, and mutantfactor should be done in very hih%ris patients. +creenin is difficult once
anticoaulation has beun. "or instance, coumarin derivatives interfere with
measurements of proteins 9 and + and the functional assay for activated protein 9
resistance, heparin reduces circulatin levels of antithrombin ---, and antiplatelet
drus may produce false neatives when testin for heparin%induced
thrombocytopenia.
e(uence o% Patho"o#y
'he venous lumen is most often recanali6ed after an episode of >'. 'his process is
a result of spontaneous lysis and involves a complex series of cellular and humoral
processes. Orani6ation of the thrombus beins at the attachment 6one as endothelial
cells activate thrombus%bound plasminoen. 'his results in enlarin pocets within
the thrombus and eventual framentation. 'he clot itself underoes softenin and
contraction durin this process, with the potential to restore the venous lumen. +erial
studies usin duplex ultrasonoraphy show that the process of recanali6ation beins
by day D in rouhly (1 percent of thromboses and is uniformly observed by =1 days.
Recurrent thrombotic events compete with recanali6ation early in the course of a
>'. 'his encompasses those patients with propaation of clot in previously
uninvolved areas, thromboses in another extremity, and rethrombosis of a partially
recanali6ed sement. 'he incidence of these recurrences is reduced tenfold when patients are iven adeAuate anticoaulation therapy for a B%month period.
C"inica" )ani%estations
'he site of venous obstruction determines the level at which swellin is observed
clinically !"i. #$%B&. 9alf vein thrombosis is locali6ed to one or more of the three
ma/or named veins below the nee. 9alf tenderness is freAuently present, but because
the thrombi are rarely completely obstructive and the veins are paired, swellin is not
a universal findin. "emoral vein thrombosis usually is associated with swellin of
the foot and calf. -liofemoral venous thrombosis represents the most extensive form of
>' and usually is associated with tenderness in the roin and swellin of the entire
le. Ma/or venous thrombosis involvin the deep venous system of the thih and pelvis produces a characteristic presentation of pain and extensive pittin edema. 'he
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 5/29
extremity may have bluish discoloration !phlemasia cerulea dolens& or blanchin
!phlemasia alba dolens, or ?mil le@&. 'he latter usually occurs in association with
prenancy. Other mechanical factors that can affect the left iliac vein include
compression from the riht iliac artery, an overdistended bladder, and conenital
webs within the vein. 'hese factors are responsible for the observed 3:$
preponderance of left versus riht iliac vein involvement.
*hlemasia cerulea dolens occurs when the venous thrombosis proresses and
impedes most of the venous return from the extremity. 'here is daner of limb loss
from cessation of arterial flow. "ortunately, this occurrence is rare. Loss of sensory
and motor function and venous anrene are liely unless an aressive approach is
implemented to remove the thrombus and restore blood flow. 'his condition almost
always occurs with advanced malinant disease.
Dia#nosis
Only 31 percent of patients with venous thrombosis have any clinical sins of the
disorder. )omans2s test is performed by dorsiflexin the foot. -t is considered positivefor >' if the patient complains of calf pain. "alse% positive clinical sins occur in
more than B1 percent of patients studied. enous duplex ultrasonoraphy has
releated other noninvasive tests, such as radioactive%labeled fibrinoen scans and all
types of plethysmoraphy, to historical interest. -n some centers duplex scans have
replaced contrast venoraphy as the best dianostic test for >'. 7ccuracy rates
above =1 percent have been consistently reported for venous duplex exams.
-ndications for duplex venous scans include patients with pulmonary emboli, patients
with extremity pain or swellin, and patients at increased ris for developin a >'.
'he latter roup includes those with trauma, /oint replacement, other ma/or sureries,
proloned immobili6ation, and nown hypercoaulability states.
'here are three essential phases to the venous duplex scan: !$& thrombus visuali6ation,
!#& vein compressibility, and !B& venous flow analysis. 7ccuracy is dependent on the
examiner2s sill. 'hrombus may be difficult to visuali6e in its acute form, and the
addition of color flow imain facilitates the identification of nonoccludin clots.
'hrombus echoenicity increases with ae of clot. enous compressibility is
determined by placin the probe directly over the vein and applyin entle pressure
while observin under 8%mode imain !"i. #$%3&. eins filled with thrombus do not
collapse with this maneuver. enous flow assessment evaluates the respiratory
phasicity and response to external extremity compression. *ersistent lac of a flow
sinal indicates total obstruction. 7 neative scan performed by a well% trainedultrasonorapher is sufficient to rule out a >' of the lower extremity.
'he role of venoraphy has been diminished by the advances in ultrasound
technoloy. 4onetheless, the in/ection of contrast material for direct visuali6ation of
the venous system of the extremity remains the most accurate method of confirmin
the dianosis of venous thrombosis and the extent of involvement. 'he main
indication for its use in the dianosis of an acute >' is a nondefinitive duplex scan.
-n/ection usually is made into the foot while the superficial veins are occluded by
tourniAuet, and a supplemental in/ection into the femoral veins may be reAuired to
visuali6e the iliofemoral system !"i. #$%(&. *otential false%positive examinations may
result from external compression of a vein or washout of the contrast material fromvenous flow from collateral veins.
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 6/29
P$ophy"a*is
8ecause the first manifestation of a >' may be a fatal pulmonary embolus, some
form of prophylaxis is indicated in hih%ris patients. *atients older than D1 years of
ae, those with previous thromboembolism, malinant disease, paralysis, multiple
trauma, or lower extremity /oint surical procedures have a very hih ris for >'.*rophylactic measures are directed toward alterin blood coaulability or eliminatin
or reducin venous stasis.
5fforts to reduce stasis include elastic compression stocins, intermittent external le
compression, le elevation, and early ambulation. -ntermittent pneumatic le
compression is the most effective measure. -t reduces stasis and increases fibrinolytic
activity with virtually no side effects. 'he pneumatic boots can be applied in the
operatin room to minimi6e the ris of venous thrombosis beinnin under eneral
anesthesia and are of proven efficacy in patients underoin total nee replacement,
radical prostatectomy, or operations where ad/uvant anticoaulation therapy is
contraindicated.
*harmacoloic prophylaxis includes low%dosae unfractionated heparin !E")&,
ad/usted%dose heparin, low%molecular% weiht heparin !LM;)&, warfarin
!international normali6ed ratio #.1FB.1&, and dextran D1. *rophylactic low%dosae
subcutaneous E") that does not alter the clottin profile has been extensively tested
and is safe and effective in moderate%ris patients. 7 (111%unit dose is iven
subcutaneously # h preoperatively and then every $# h postoperatively for < days.
'his provides protection for most hih%ris roups with the exception of those
underoin orthopaedic or uroloic procedures. )iher% ris patients reAuire ad/usted%
dose E") with the activated partial thromboplastin time !7*''& held in the upper
normal rane. 8oth reimens are associated with an increased incidence of wound
hematomas. 'he studies comparin the prophylactic use of LM;) and E") have
concluded that there is little difference between the two drus. LM;) is ten times
more costly than E"), however.
'here are ood data to support the use of preoperative oral anticoaulant therapy with
coumarin derivatives in hih%ris patients. ;hen iven the niht before operation,
warfarin anticoaulation is achieved within B to 3 days. 'he ?two%step@ or minidose
warfarin reimen is desined to circumvent the delay in anticoaulation. ;arfarin is
started at a dose of $ m $3 days before operation to prolon the prothrombin time
!*'& by # or B seconds. 'his procedure increases the ris of hemorrhae, and becauseof the added difficulties of laboratory control of prothrombin time, there has not been
widespread acceptance of this approach. 7 national tas force on prophylaxis for
patients underoin hip surery recommends warfarin or ad/usted%dose heparin to
prolon the 7*'' to the upper normal rane. 'he administration of dextran, which
produces a variety of effects on platelets and clottin factors, has been demonstrated
to reduce the incidence of detectable thrombi. -t too can produce hemorrhaic
problems, alleric reactions and, in older patients, conestive heart failure.
Recommendations for prophylaxis are listed in 'able #$%#.
)edica" T$eatment
'he approach to manaement of the patient with >' is based on three ob/ectives:minimi6in the ris of pulmonary embolism, limitin further thrombosis, and
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 7/29
facilitatin resolution of existin thrombi to avoid the postthrombotic syndrome. 'he
traditional treatment places the patient at bed rest with the foot of the bed elevated 0
to $1 inches. -ntravenous E") is administered, and oral warfarin is started when the
patient2s 7*'' is in a satisfactory rane. 7s the pain, swellin, and tenderness resolve
over a ( to D day period, ambulation is permitted with elastic stocin support.
+tandin still and sittin should be prohibited to avoid increased venous pressure andstasis. *atients with lare thrombus loads are candidates for fibrinolytic aents in an
attempt to preserve venous valvular competence. 'he practice of mandatory bed rest
and hospitali6ation has been challened by the encourain results of outpatient
treatment of >' with LM;).
Anticoa#u"ation
'he foundation of therapy for >' is adeAuate anticoaulation, initially with heparin
and then with coumarin derivatives for proloned protection aainst recurrent
thrombosis. Enless there are specific contraindications, heparin should be
administered in an initial dose of $11 to $(1 unitsC intravenously. )eparin is an acid
mucopolysaccharide that neutrali6es thrombin, inhibits thromboplastin, and reducesthe platelet release reaction. -t may be administered by continuous or intermittent
intravenous doses reulated by whole blood clottin time or 7*''. Recurrent
episodes of thromboembolism are $( times more common in patients with inadeAuate
anticoaulation treatment within the first #3 hours. 8leedin complications can be
minimi6ed by doses of heparin that prolon the laboratory clottin determinations by
about twice the normal time. 9ontinuous intravenous infusion reulated by an
infusion pump minimi6es the total dose reAuired for control and is associated with a
lower incidence of complications and no loss of effectiveness.
'hrombocytopenia is the most common complication of heparin therapy and is
estimated to occur in $ to ( percent of patients receivin the dru. Enlie other dru%
induced thrombocytopenias, heparin%induced thrombocytopenia often is associated
with thromboembolic complications from antibody%mediated platelet activation. 'he
paradox of thrombosis occurrin in a patient receivin heparin was first described in
$=(0 by ;eismann and 'obin. 'owne and associates described the ?white clot@
syndrome, a peripheral vascular complication of heparin therapy in $=D=. )eparin%
induced thrombocytopenia !)-'& represents the prodrome to the thrombotic syndrome
!)-''+& that occurs in $ in #111 patients who receive more than #1,111 -E of E")
per day for more than ( days, $ in ( patients with )-', and $ in B patients who have
heparin%dependent antiplatelet antibodies. *atients who develop )-''+ have a
mortality rate ranin from #( to BD percent resultin from diffuse uncontrolledclottin with limb ischemia and oran infarction. 'here are no nown factors that
predict ris. >evelopment of thrombocytopenia from heparin is independent of sex,
ae, blood type, amount of heparin iven, type of heparin, and route of administration.
)-' has been documented after minimal heparin dosaes such as those received with
-.. flushes and heparin% coated indwellin catheters.
'wo forms of )-' exist. 'ype -, the most freAuent, is mild !platelet counts
$11,111CmmB&, reverses despite continuation of heparin, is due to a direct pro%
areant effect of heparin, and is not associated with thromboses. -n contrast, 'ype
-- )-' is severe !platelet counts H$11,111CmmB&, resultin from antibodies bindin to
a platelet%heparin complex that leads to platelet activation and areation and isoften associated with arterial or venous thromboses. 'he thrombocytopenia typically
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 8/29
occurs after ( days of heparin therapy but can occur earlier in patients who have a
prior exposure to heparin. 'ype -- )-' reAuires the immediate withdrawal of all
heparin.
'he most important advantae of the LM;)s over E") is their superior
pharmacoinetic properties, allowin their use without laboratory monitorin. LM;) preparations have been compared with E") for the acute treatment of >' in $B
well% desined trials. *ooled results from these studies show that LM;)s
administered subcutaneously are as effective and safe as E") but have the advantae
of the potential for home treatment and do not reAuire laboratory monitorin. 'hese
advantaes may offset the increased cost of LM;).
Oral administration of anticoaulants is beun shortly after initiation of heparin
therapy. 'here is a ris in ivin coumarin derivatives to a patient who is not already
anticoaulated with heparin. 'he coumarin derivatives bloc the synthesis of the
vitamin K%dependent clottin factors and inhibit vitamin K carboxylation of proteins
9 and +. 'hese latter proteins are naturally occurrin anticoaulants that function byinhibitin activated factors and ---. 7 vitamin K antaonist potentially can create
a hypercoaulable state before achievin its anticoaulant effect because the half%lives
of proteins 9 and + are shorter than the half%lives of the other clottin factors. )eparin
should be continued for the 3 to ( days reAuired to achieve full anticoaulation with
coumarin derivatives.
>ata from prospective studies indicate that the level of anticoaulation with coumarin
derivatives are effective at an international normali6ed ratio of #.1 to B.1. )iher
levels are not more effective and are associated with a hiher incidence of bleedin
complications. 7dministration of fresh fro6en plasma usually can normali6e the
prothrombin time and control hemorrhaic complications. 9oumarin derivatives cross
the placenta and should not be used durin prenancy. 7fter an episode of acute >',
anticoaulation therapy should be maintained for a minimum of B months some
investiators favor < months for treatment of thrombi in the larer veins. Many drus
interact with coumarin derivatives !e.., barbiturates&, and it is essential that a routine
for reular monitorin of prothrombin time be established after the patient leaves the
hospital.
Th$om'o"ysis
7nticoaulant therapy is desined to prevent recurrent thromboembolism. -deally, a
treatment would be available with the potential to eliminate the thrombus andmaintain valvular function. 7 number of trials have been performed comparin
thrombolysis with standard anticoaulant therapy. 9omplete clearin of thrombus was
noted in 3( percent of patients treated with thrombolytic aents, compared to 3
percent of those treated with heparin. 'his seems to translate into a lon%term
improvement in venous function. *opliteal valve incompetence was documented in DD
percent of those patients who did not have clearin, compared to a = percent incidence
in those with complete lysis. 'hese aents have no advantae over heparin in the
treatment of recurrent venous thrombosis or thrombosis that has existed for more than
D# h, and they are contraindicated in postoperative or posttraumatic patients.
'here are more bleedin complications with thrombolytic treatment, and thisapproach is reserved for those patients with clot in the common femoral and iliac
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 9/29
venous systems. -n a prospective study of #= patients with thrombosis involvin the
popliteal veins, with or without involvement of calf veins, Kaar compared
hemodynamic and clinical results in patients receivin (%day treatment with heparin
or streptoinase, followed by a <% month course of a coumarin derivative. Overall, at
#%year follow%up they found more than half of the limbs to have evidence of the
postthrombotic syndrome. 9linically, $3 percent of patients had no symptoms, #1 percent had severe symptoms, and the remainder demonstrated mild to moderate
chanes. 4o difference was seen between patients receivin heparin or streptoinase.
'hese studies were done with systemic infusion of lytic aents. +tudies evaluatin the
use of catheter%directed thrombolysis have had encourain results in selected areas
and are discussed in detail in the section +ubclavian ein 'hrombosis.
u$#ica" App$oachesOpe$ati&e Th$om'ectomy
'here are very few indications for operative thrombectomy because catheter%directed
thrombolysis is so effective in treatin iliofemoral venous thrombosis. 'he procedure
is reserved for limb salvae in the presence of phlemasia cerulea dolens and
impendin venous anrene and in patients with a contraindication to thrombolysis.
'he direct surical approach to remove thrombi from the deep veins of the le uses
the common femoral vein and is facilitated by the use of a "oarty venous balloon
catheter and an elastic wrap for milin the extremity !"i. #$%<&. Results are
improved when the extent of thrombus is documented preoperatively, when
completion phleboraphy is performed to assure complete clot removal, when a small
arteriovenous fistula is constructed to maintain hih blood flows in the iliac vein, and
when anticoaulation therapy is iven over proloned periods. 5arly results in (D
patients treated in this fashion reported by 5inarsson and associates showed patency
of the iliofemoral sement by venoraphy in <$ percent, and D( percent had a oodclinical result. Measurement by venous function, however, usin plethysmoraphy
and foot volumetry, showed normal results in only #= percent.
'he use of arteriovenous fistulas after iliofemoral thrombectomy or reconstruction of
the venous system is controversial. Most of the experience has been accumulated in
5urope, where it is believed to reduce the incidence of early rethrombosis. 'he two
most commonly used sites are the femoral trianle and the anle. 7fter surery on the
iliofemoral system, an )%shaped fistula can be established easily by anastomosin a
branch of the saphenous vein end%to%side to the proximal portion of the superficial
femoral artery. 7t the anle, the posterior tibial artery may be anastomosed to the
posterior tibial vein or the reater saphenous vein. 'wo problems have led to thereluctance of some sureons to adopt this procedure: the fear of damain functionin
valves distal to the fistula and the reAuirement for a second operation to close the
fistula. "istulas usually are closed B to 3 months postoperatively, and problems with
incompetent valves distal to the fistula have not been reported. 'wo steps durin
primary venous reconstruction simplify operative closure of the fistula later. 'he
fistula is made distal to the venous reconstruction, avoidin damae to this area at
reoperation, and a liature is wrapped around the fistula and left in the subcutaneous
tissue, where it can be found under local anesthesia. Obliteration of the fistula
percutaneously by a detachable balloon has been described.
Vena Ca&a" !nte$$uption
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 10/29
ena caval interruption also is indicated when there is a contraindication to or failure
of anticoaulation therapy !'able #$%B&. 5arly operations in which one or both
common femoral veins were liated were associated with hih recurrence rates and a
hih incidence of seAuelae because of stasis in the lower extremity. 9ontrol of the
inferior vena cava for liation reAuired a laparotomy and added the adverse effect of a
sudden reduction in cardiac output under eneral anesthesia. 'his effect, coupled withstasis seAuelae and recurrent embolism throuh dilated collateral veins, led to efforts
to compartmentali6e the vena cava by means of sutures, staples, and external clips in
order to provide filtration without occlusion !"i. #$%D&.
8ecause these procedures reAuired eneral anesthesia and laparotomy, the next loical
step was to devise a transvenous approach that could be performed under local
anesthesia. 'he Mobin%Eddin ?umbrella@ unit was inserted from the /uular vein and
positioned under fluoroscopic control below the renal veins. 'he incidence of vena
cava occlusion was D1 percent, and fatal embolism sporadically occurred with device
miration.
'he Greenfield cone%shaped filter was developed to maintain patency after trappin
emboli. 'his is possible because of the eometry of the cone, which collects emboli in
its apex and retains perimeter flow. *reservation of flow avoids stasis and facilitates
lysis of the embolus !"i. #$%0&. -t can be inserted percutaneously from either the
/uular vein or the femoral vein. 'he rate of recurrent embolism with this device has
been 3 percent over $# years of follow%up. -ts lon%term patency rate in excess of =(
percent allows it to be placed above the renal veins when necessary for embolism
control, such as when there is a thrombus within the renal veins or the vena cava.
'here are a number of proprietary devices available for percutaneous insertion that are
eAually successful in preventin pulmonary embolism.
upe$%icia" Th$om'oph"e'itis
'he term thrombophlebitis should be restricted to a disorder of the superficial veins
characteri6ed by a local inflammatory process that usually is aseptic !"i. #$%=&.
*atients present with a painful swellin and erythema alon the course of a superficial
vein. 'he cause of thrombophlebitis in the upper limb usually is acidic fluid infusion
or proloned cannulation. -n the lower extremity it is often associated with varicose
veins and may coexist with >'. -ts association with the in/ection of contrast
material can be minimi6ed by washout of the contrast material with heparini6ed
saline. 'he dianosis usually is obvious. >uplex scans are very accurate in confirmin
the dianosis and should be performed especially when swellin is present to rule outa concomitant deep venous problem.
+ymptoms usually last for # to B wees. 4onsteroidal anti% inflammatory aents
provide sinificant pain relief. *atients should not be ept at bed rest. 7ctivity should
be encouraed with the extremity in external elastic support. -f the thrombus extends
into the saphenofemoral /unction, the patient should have the saphenous vein
disconnected from the common femoral vein or undero full anticoaulation therapy.
Th$om'oph"e'itis )i#$ans
'hrombophlebitis mirans, a condition of recurrent episodes of superficial
thrombophlebitis, can be associated with visceral malinancy, 8uerer2s disease, thehypercoaulable states, systemic collaen vascular disease, and blood dyscrasias.
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 11/29
-nvolvement of the deep veins and the visceral veins also has been described. 'he
presence of this condition should alert the clinician to search for an underlyin
condition.
u'c"a&ian Vein Th$om'osis
+ubclavian venous thrombosis !+'& may be associated with an anatomicabnormality at the thoracic outlet, may be related to the placement of a central venous
catheter, or may occur in a hypercoaulable patient. -f left untreated, #( to D3 percent
of affected patients will have some limitations in activity, as many as $# percent will
have a pulmonary embolus, and $ percent will die. 'hose cases related to a thoracic
outlet abnormality mae up 1.( percent to $.( percent of all venous thromboses and
often are associated with strenuous activities. 'hese cases are referred to as the *aet%
+chroetter syndrome or ?effort thrombosis.@ 9atheter%induced thrombosis is an
increasinly common event because of the more freAuent use of central veins for
access, nutrition, chemotherapy, and monitorin. +creenin venoraphy in patients
with central venous catheters demonstrates that BB to <1 percent have thrombus in the
axillosubclavian sements. 9linically evident +' develops in B percent of these patients.
*atients with +' present with a bluish, swollen arm and a pattern of upper extremity
venous hypertension. 9ollateral veins usually are visible around the shoulder and
chest wall. *atients typically describe an achin pain that is exacerbated by exercise.
'he color duplex scan has virtually replaced contrast venoraphy in the dianosis of
lower extremity venous thrombosis, but the opposite is true in the upper extremity.
enoraphy has a reater dianostic accuracy when performed with the catheter in
the basilic vein. 7 typical +' is shown in "i. #$%$1.
>ata support a role for conventional anticoaulation in all patients with +' for
prophylaxis aainst pulmonary embolism and for reduction of residual symptoms.
7ressive surical therapy focused on clot removal is no loner recommended.
-nstead, physically active patients with +' dianosed in the acute phase should
undero catheter%directed thrombolysis. 9urrent protocols recommend uroinase
delivered via a catheter placed throuh the thrombus. 'his approach is successful in
more than (1 percent of patients and ideally identifies the anatomic cause of the
thrombosis !"i. #$%$$&. 7lthouh the timin of correction is debated, most sureons
aree that extrinsic and extrinsic venous lesions should be aressively treated. 'his
means eliminatin the compression at the costoclavicular space by a transaxillary first
rib resection or a medial claviculectomy. 'he former is used when a direct approachto the vein is not reAuired the latter is used when the vein reAuires repair.
!n%e$io$ Vena Ca&a" Th$om'osis
'hrombosis of the inferior vena cava can result from tumor invasion or propaatin
thrombus from the iliac veins. 'umors of the vena cava are rare and are usually
malinant and have a poor pronosis. 'hey may be primary, such as a
leiomyosarcoma, or secondary, such as a hypernephroma and a retroperitoneal
sarcoma. +ymptoms and sins depend on the sement of vena cava affected by the
tumor and the deree of obstruction of ad/acent orans. -nvolvement of the
suprahepatic cava may cause the 8udd%9hiari syndrome. 'he dianosis can be made
with a variety of imain modalities, includin manetic resonance imain !MR-&,computed tomoraphy !9'&, ultrasonoraphy, and contrast cavoraphy.
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 12/29
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 13/29
Pu"mona$y Th$om'oem'o"ism
*ulmonary embolism is the third leadin cause of death from cardiovascular events,
second only to myocardial infarction and stroe. 5stimates of the mortality in the
Enited +tates alone rane from (1,111 to #11,111 per annum. -t may be the most
common form of preventable hospital death. -t is estimated that ( of every $,111
adults underoin ma/or surery will die from massive pulmonary embolism.
irchow first reconi6ed the association between the venous thrombosis and
pulmonary embolus after performin autopsies in D< patients with antemortem
thrombi obstructin their pulmonary arteries. -t also became obvious in the early
reports by patholoists that pulmonary embolism could be well tolerated by some
patients who then died of other causes. 'he full spectrum of the disorder ranes from
asymptomatic minor embolism to sudden death from massive embolism. 7utopsy
studies consistently demonstrated a $1 to $( percent incidence of fatal pulmonary
embolism until the $=D1s. ;ith aressive prophylaxis, the incidence has been
reduced to < percent.
C"inica" )ani%estations
'he sins and symptoms of an embolic episode depend primarily on the manitude of
embolus and, to a lesser extent, on the cardiopulmonary status of the patient. Less
than BB percent of patients with documented pulmonary embolism show clinical sins
of venous thrombosis. 'he dianosis is unsuspected in the ma/ority of patients who
die of pulmonary embolism. 'he vast ma/ority of patients suddenly develop chest
pain or dyspnea. Other early symptoms may include tachypnea, diaphoresis, and
mared anxiety. )emoptysis is an uncommon sin, and when present it usually occurs
late in the course of the disease and represents pulmonary infarction. Ob/ectively, the
patient with ma/or embolism usually shows tachycardia, an increased pulmonary
second sound, cyanosis, prominent /uular veins, and varyin derees of collapse.
Less commonly, there may be whee6in, a pleural friction rub, splintin of the chest
wall, rales, low% rade fever, ventricular allop, and wide splittin of the pulmonic
second sound. 'he incidence of these findins found in the Eroinase *ulmonary
5mbolism 'rial is shown in 'able #$%3.
'he differential dianosis includes esophaeal perforation, pneumonia, septic shoc,
and myocardial infarction. 8ecause all these entities are life% threatenin, it is
mandatory that an orderly approach be formulated to confirm or re/ect the worin
dianosis. Laboratory studies in eneral are not very helpful in the differential
dianosis, althouh a white blood cell count of less than $(,111CmmB miht besuestive when a pulmonary infiltrate is present to help rule out pneumonitis.
Dia#nostic tudies
5lectrocardioraphy
'he primary value of the electrocardioram !59G& is to rule out a myocardial
infarction. -n the presence of a pulmonary embolus, the 59G may have sins of riht
ventricular overload such as the +$, IB, 'B pattern. 'his only occurs in $< percent of
patients with documented pulmonary embolism. More commonly, the 59G has
nonspecific +' and ' wave chanes that are nondianostic.
Chest Radio#$aphy
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 14/29
'he primary value of the chest radioraph is to exclude other dianostic possibilities,
such as pneumonia, pneumothorax, esophaeal perforation, or conestive heart
failure. 7lthouh central vascular enlarement, asymmetry of the vascular marins
with semental or lobar ischemia !;estermar2s sin&, or pleural effusion may
suest pulmonary embolism, they are rarely sufficient to establish a dianosis. 'he
chest radioraph is critical in the interpretation of a lun scan, because anyradioraphic density or evidence of chronic lun disease maes a perfusion defect less
liely to represent a pulmonary embolism. *ulmonary infarction as a conseAuence of
embolism is a rare findin. A +ed#e-shaped density usua""y is seen on the chest
radioraph !"i. #$%$#&.
A$te$ia" ,"ood ases
)ypoxemia with *aO # of less than <1 mm) is hihly suestive of pulmonary
embolism, especially when the chest radioraph does not show any other pulmonary
patholoy. 'he low *aO # is believed to be a result of shuntin by overperfusion of
nonemboli6ed lun and a widened alveolar% arterial oxyen radient from reduced
cardiac output. 'he reduction in arterial *9O # that follows ma/or embolism is themost discriminatin findin because hypoxemia is present in several disorders liely
to be misdianosed as massive embolism !e.., septic shoc&. -f hypoxemia and
hypocapnia are not present, the dianosis of ma/or embolism in the severely ill patient
is unliely, and an alternative dianosis should be souht.
Cent$a" Venous P$essu$e
Low central venous pressure !9*& virtually excludes pulmonary embolism as the
primary cause of the hypotension because massive embolism almost always is
accompanied by riht ventricular overload and elevated riht atrial pressures.
5levated riht ventricular fillin pressures may be transient, however, as
hemodynamic accommodation occurs, and in subacute or chronic embolism the
central venous pressure may be normal.
Lun# can
'he most commonly used dianostic test is the perfusion lun scan. 7 normal scan
rules out a ma/or pulmonary embolus, but an abnormal scan does not ensure the
dianosis. -n a nonhypotensive patient with a normal chest radioraph, the lun scan
is a valuable screenin test that has increasin validity as the si6e of the perfusion
defect approaches lobar distribution !"i. #$%$B&. +maller peripheral perfusion defects
are more difficult to interpret because pneumonitis, atelectasis, or other ventilation
abnormalities alter pulmonary perfusion. ;hen the ventilationC perfusion lun scan isinterpreted as hih probability, the dianostic accuracy as compared to pulmonary
anioraphy is =< percent.
Pu"mona$y A$te$io#$aphy
+elective pulmonary arterioraphy is the most accurate method of confirmin the
presence of pulmonary emboli and should be performed for any eAuivocal
ventilationCperfusion scan. 'he procedure is invasive, reAuirin passae of a cardiac
catheter into the pulmonary artery for in/ection of a bolus of contrast medium. 7
series of radioraphs that outline areas of decreased perfusion and usually show fillin
defects or the rounded trailin ede of impacted emboli !"i. #$%$3& is obtained.
+traiht cutoffs of the smaller pulmonary arteries are more difficult to interpret, particularly if there is associated chronic lun disease that obliterates pulmonary
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 15/29
vessels. 'he procedure can be performed with low ris, althouh pulmonary
hypertensive and cardiac patients are at hihest ris for this type of study, which
usually carries a 1.B to 1.( percent mortality rate. 7voidance of in/ection of contrast
medium into the main pulmonary artery minimi6es the complications and mortality
rates. 7dditional useful information is obtained before contrast in/ection by
measurement of pulmonary arterial pressures. 7 normal pulmonary anioramexcludes the dianosis of pulmonary embolism in acutely ill patients.
Pathophysio"o#y
-t is estimated that 0( to =1 percent of all pulmonary emboli oriinate from the veins
of the lower extremity, and the remainder arise from the riht side of the heart or
other veins. Once the embolus has loded and interrupted pulmonary blood flow, the
ratio of reional ventilation to perfusion increases, and the lun responds by
bronchoconstriction to reduce wasted ventilation. 'his response is mediated by a local
reduction in 9O#output because it can be prevented by ventilation with increased
concentration of 9O#. 'he bronchoconstriction is exacerbated by the release of
serotonin from platelets adherent to the embolus. 'he ability of heparin to inhibit therelease of serotonin adds further /ustification to the early use of this dru. Other
vasoactive aents, such as histamine and prostalandins, may have a role, but the net
effect is a reduction in si6e of peripheral airways, reduced lun volume, and reduced
static pulmonary compliance. 'he hypoxemia that characteri6es ma/or embolism is
thouht to be due to a ventilation% perfusion imbalance secondary to the ventilation
chanes described above, althouh the findins in some patients resemble true
arteriovenous shuntin. 7lthouh there may be some improvement in *aO #after
supplemental oxyen is administered, the effects usually are minimal. 'he pulmonary
vascular and cardiac effects of embolism are a direct conseAuence of the deree of
occlusion of the pulmonary vascular bed. 'he loss of more than B1 percent of the
vascular tree is reAuired to bein to elevate mean pulmonary artery !*7& pressure, and
usually more than (1 percent occlusion is reAuired to reduce systemic pressure.
T$eatment
Anticoa#u"ation
'he hemodynamic variables previously described provide a means of classification of
patients that uses four rades of severity and is a useful uide to therapy and
pronosis !'able #$%(&. 'he minor derees of embolism usually can be manaed with
anticoaulants alone with a satisfactory outcome. 9ontinuous%infusion heparin is the
initial treatment, in a dosae desined to prolon the partial thromboplastin time to at
least twice normal !approximately $(1 unitsC &. Most clinicians also bein oralanticoaulation therapy to allow several days2 overlap of the drus as prothrombin
time is extended into the therapeutic rane. 7deAuate anticoaulation stops the
proression of thrombosis and is associated with a recurrence rate of less than (
percent.
.i'$ino"ytic The$apy
5mboli typically undero dissolution as a result of the active fibrinolytic mechanism
in the pulmonary circulation. 7ctivation of plasminoen to plasmin, which is found in
hih concentration in the pulmonary circulation, promotes this fibrinolytic effect.
"ibrinolytic aents have been administered to increase the rate of lysis after
pulmonary embolism/ Tissue p"asmino#en acti&ato$ 0t-PA wors more rapidly thanu$oinase3 but both are costly and are associated with a hih incidence of bleedin
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 16/29
complications. -ndications for fibrinolytic treatment include any critically ill patient
with a pulmonary embolus. 8leedin complications can be reduced by tain a
careful neuroloic history to eliminate patients with any brain patholoy, minimi6in
venous and arterial punctures, stoppin heparin administration, and identifyin any
other potential causes of bleedin.
'he advantae of thrombolytic therapy may well be to improve the ultimate resolution
of ma/or thromboembolism, as demonstrated by +harma and associates. 'heir follow%
up studies in patients treated with uroinase or streptoinase showed a better
restoration of pulmonary%capillary blood volume and diffusin capacity at # wees
than in patients treated with heparin and anticoaulants alone. 'he reason for the
continued improvement at $ year was not clear but was believed to be related to more
complete early resolution of the embolic condition, allowin more effective natural
lytic processes, or to more complete clearance of peripheral venous thrombi,
preventin silent recurrent embolism. 'herefore, the patient who is not in shoc and
who has no clear contraindication should be treated with a fibrinolytic aent.
Vena Ca&a" !nte$$uption
-n some patients, anticoaulants cannot be used because of associated problems !e..,
peptic ulcer disease&, and manaement must be directed toward a mechanical means
of protection aainst recurrent embolism as outlined earlier !see 'able #$%B&. Other
patients, in whom anticoaulation appears to be adeAuate, sustain recurrent embolism
and become candidates for surical intervention. 'he third indication is when there
has been a complication of anticoaulant therapy, forcin it to be discontinued and
leavin the patient with untreated >'. 7nother indication for a vena caval filter is
protection aainst recurrent embolism in a patient who has sustained massive
pulmonary embolism reAuirin open or catheter embolectomy. -n these patients, in
spite of a satisfactory embolectomy of the pulmonary circulation, the oriinal focus of
venous thrombosis remains untreated and recurrent embolism is liely.
'here are two additional relative indications for a vena caval filter in a patient with
active or recent >'. One is the hih% ris patient over 31 years of ae who is obese
and has a serious associated medical illness !e.., heart disease&, malinant disease, or
a history of previous embolism and who underoes a ma/or abdominal or vascular
procedure. 'he final relative indication is the patient in whom 31 to (1 percent of the
vascular bed has been occluded !ma/or& and who would most liely not be able to
tolerate additional emboli, particularly if there is associated cardiac or pulmonary
disease.
Pu"mona$y Em'o"ectomy
'he direct surical approach to pulmonary embolism can be traced bac to
'rendelenbur !$=10&, who demonstrated the feasibility of pulmonary embolectomy
experimentally but had no successes clinically. -t remained for his pupil Kirschner
!$=#3& to confirm the possibility of embolectomy by a successful clinical outcome.
8ecause this procedure was attempted without circulatory support usin a direct
approach to the pulmonary artery at thoracotomy, the number of survivors was very
small, and the first successful case in the Enited +tates was not reported until $=(0 by
+teenbur. 'he first successful open embolectomy durin cardiopulmonary bypass
was reported by +harp in $=<#. +ince then, partial bypass support has also been usedfor the patient in shoc. Local anesthesia is used, and the femoral artery and vein are
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 17/29
cannulated for venoarterial bypass. 'he eAuipment is fully portable !"i. #$%$(&, and
patients can be supported durin pulmonary arterioraphy and then transported to the
operatin room, where they can tolerate eneral anesthesia and sternotomy much
better while bein maintained on partial cardiopulmonary bypass.
5merency pulmonary embolectomy rarely is indicated but should be considered inany patient with an acute pulmonary embolism who appears preterminal. 'hese
patients rarely survive the trip to the anioraphy suite and operatin room, but when
they do, the operation is probably not necessary if fibrinolytic therapy is available.
>ocumentation of the dianosis of massive pulmonary embolism by pulmonary
arterioraphy is mandatory because the clinical dianosis often is incorrect. 'he initial
approach to patients who have transient collapse or persistent systemic hypotension
should include full heparini6ation and administration of inotropic drus, if necessary,
to support the circulation while the dianosis is confirmed. -soproterenol !3 m in
$111 mL of (J dextrose in water& is useful initially because of its bronchodilatin
and vasodilatin effects and its positive inotropic cardiac effect. -t may provoe
arrhythmias, however, necessitatin the use of dopamine. -n the patient who respondsto heparin and does not reAuire vasopressors for systemic pressure or urine output,
careful monitorin is essential to determine whether anticoaulation and fibrinolysis
will control the disorder. Open pulmonary embolectomy carries a mortality rate in the
rane of (1 percent, however, and uncontrollable pulmonary hemorrhae may follow
open restoration of pulmonary perfusion.
7n alternative approach usin local anesthesia has been suested by Greenfield and
associates for transvenous removal of pulmonary emboli. 7 cup device attached to a
steerable catheter is inserted in the /uular or the femoral vein, and the cup is
positioned under fluoroscopy ad/acent to the embolus seen on arterioraphy !"i. #$%
$<&. 'he position is verified by in/ection of contrast medium throuh the catheter.
'hen syrine suction is applied to aspirate the embolus into the cup, where it is held
by suction vacuum as the catheter and captured embolus are withdrawn. 9linical
experience with the techniAue in B# patients demonstrated that emboli could be
extracted in #= of them !=$ percent& with an overall survival rate of D< percent.
5mboli could not be removed when they had been impacted for more than D# h or if
the patient suffered cardiac arrest at the time of anioraphy, in which case open
embolectomy was reAuired. *lacement of a Greenfield vena caval filter after removal
of sufficient emboli to produce near% normal hemodynamics protected the patients
from recurrent embolism.
Pu"mona$y Hype$tension and Th$om'oem'o"ism
*ulmonary emboli may accumulate radually over a proloned period if they fail to
undero lysis and obliterate the pulmonary vascular bed. 'he clinical picture in this
case is one of chronic cor pulmonale because sinificant pulmonary hypertension
results from chanes in the pulmonary vascular bed. 'he presentation may be subtle
with only dyspnea or syncope on exertion, but there is a loud *# and riht%sided strain
on the electrocardioram. 'he seAuence also may occur unaccompanied by sinificant
respiratory symptoms, and this may explain the cause in some of the patients
considered to have primary pulmonary hypertension. ;hen the dianosis is made,
there is limited life expectancy, but the patient may benefit from a vena caval filter to
prevent additional embolism even if the disorder is primary pulmonary hypertension,as reported by Greenfield and associates. 'he rationale for this is that they ultimately
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 18/29
develop riht heart failure, predisposin to pulmonary embolism that is lethal even if
small. ;hen acute cardiopulmonary decompensation occurs in these patients after
embolism, they are not ood candidates for embolectomy because of fixation of the
older thrombi to the pulmonary arterial wall. 'hey should be classified separately
!chronic& and manaed by lon%term anticoaulation therapy, or in some cases should
be considered for open pulmonary thromboendarterectomy or heart%luntransplantation.
Recurrent thromboembolic pulmonary hypertension produces exertional dyspnea and
sins of riht heart strain with cor pulmonale. ;ith further proression of riht heart
overload, tricuspid insufficiency may develop. 'his disorder may be difficult to
distinuish from primary pulmonary hypertension, althouh the latter is more liely to
be found in women under #1 years of ae without a history of >'. +evere
pulmonary hypertension is a serious problem and usually limits the life expectancy to
less than # years from dianosis.
Open thrombectomy for chronic occlusion was first performed by 7llison andassociates in $=(0 and remains a possibility for improvin pulmonary blood flow. "or
a patient to be eliible for this procedure, the occlusion must involve the proximal
portion of the pulmonary arterial tree, and the distal bed must be patent. 'he
physioloic basis for continued distal patency after proximal occlusion is bronchial
arterial collateral flow. 'he procedure also has a sinificant mortality, but this has
been decreasin with reater experience and identification of ris factors. >aily and
associates performed pulmonary thromboendarterectomy on $#D patients under deep
hypothermic circulatory arrest with a mortality rate of $#.< percent. "or the ma/ority
of patients with severe pulmonary hypertension, however, the outloo is poor unless
they receive maximum protection from recurrent embolism, which in the authors2
experience has reAuired anticoaulation therapy and vena caval filter placement.
"i. #$%$D presents an alorithm for the manaement of pulmonary embolism.
Va$icose Veins
aricose veins are the most common vascular disorder affectin human beins. 7
definition of a varicose vein that lays the roundwor for a unified theory of causation
was iven by 9arl 7rnoldi, who described them as ?any dilated, elonated, or tortuous
vein, irrespective of si6e.@
Etio"o#y'here are four factors that affect the development and proression of varicose veins:
heredity, female sex hormones, ravitational hydrostatic force, and hydrodynamic
muscular compartment forces. 7 familial tendency toward the development of
varicosities may be the most important predisposin factor. "emale sex hormones also
have a profound effect on the lower extremity superficial veins. aricose veins are
common occurrences in prenancy, usually appearin in the first trimester !D1 to 01
percent& when the corpus luteum is secretin proesterone. *roesterone is nown to
inhibit smooth muscle contractility and increase venous distensibility. 'hese effects
are maximal on the first day of the menstrual cycle, when the effects of proesterone
are amplified by estroen. )ydrostatic forces produce venous dilatation from the
weiht of the blood column transmitted throuh incompetent valves. 'he other force
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 19/29
is exerted by the contractin muscles on ad/acent veins via the perforatin system.
'hese forces reularly exceed $(1 mm).
C"inica" )ani%estations
'he usual distribution of varices is below the nee in branches of the reater
saphenous system !"i. #$%$0&. 'he symptoms associated with varicose veins arenonspecific achin and heaviness of the les that can be attributed to the conestion
and poolin of blood in the enlared superficial venous system. 'hese symptoms
worsen as the day proresses, reAuirin the patient to rest with le elevation to obtain
relief. 9alf%lenth elastic stocin support in the rane of #1 to B1 mm) may
provide symptomatic relief for those whose vocations reAuire lon periods of standin
or sittin. 7lthouh mild edema may occur from varicosities alone, it usually reflects
additional incompetence of the deep or perforatin venous system and other medical
conditions, such as cardiac or renal failure. 7ssociated niht crampin of the les may
be helped by the administration of Auinine sulfate, which reduces muscular irritability.
Dia#nosis'he 'rendelenbur test is useful in distinuishin between primary varicose veins and
the more serious condition of varicosities secondary to underlyin deep venous
disease. -n the 'rendelenbur test the limb is elevated to evacuate the veins, then
pressure by hand or tourniAuet is applied to the saphenofemoral /unction !"i. #$%$=&.
;ith the patient standin, the lower le is observed for the rate of fillin of the
varicosities. Gradual fillin occurs in normal patients when the perforatin veins are
competent. Rapid fillin occurs if the perforators are incompetent. 'he second phase
of the test consists of release of the pressure to see if the upper thih varices fill
rapidly, indicatin incompetence of the saphenofemoral valve. 'here are four possible
results of this test. 7 neative%neative result occurs when there is only radual fillin
in the distal one%third of the le with compression in place and only continued slow
fillin when the compression is released. 'his indicates that the valves of the
perforatin veins !phase -& and superficial veins !phase --& are competent. -n a
neative%positive result, the release of compression is followed by a rapid fillin of
the saphenous vein, indicatin that its valves are incompetent. 7 positive%neative
result indicates that the perforatin veins are incompetent, but the superficial veins are
competent. 7 positive%positive result indicates that both systems have valvular
incompetence. 'hese principles have been refined by the use of color%flow duplex
scannin. 9hanes in the direction of flow are detected by chanes in color, and
venous valves may be seen on the rey% scale imae.
-n the *erthes test, a tourniAuet is placed around the upper le and the patient is
instructed to wal. -f the varicose veins disappear, the deep venous system is patent
and the perforatin veins are competent. -f pain occurs with walin, the deep system
is obstructed and the superficial system represents the ma/or source of venous
outflow. -t would be a serious error to excise superficial veins under these
circumstances. +eAuential tourniAuets also may be used to define and isolate areas of
incompetent perforatin veins !Ochsner%Mahorner test&.
T$eatment
'he ma/ority of patients can be manaed by conservative methods, but if these fail to
control symptoms or if additional complications of venous stasis develop, such as
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 20/29
dermatitis, bleedin, thrombosis, or superficial ulceration, the patient may become a
candidate for more aressive manaement.
'he two methods of treatment currently used are in/ection sclerotherapy and ablative
surery. +clerotherapy should be reserved for those patients who do not have
evidence of axial saphenous reflux. Lare varices of the thih also should be removedsurically because they are sub/ect to superficial thrombophlebitis after sclerotherapy
and are often associated with lare perforatin veins. -n/ection sclerotherapy destroys
the endothelium of the vein and promotes its obliteration by scarrin. *ressure must
be applied to the vein after in/ection of the sclerosant to prevent thrombus formation
and later recanali6ation. 'he techniAue for in/ection involves placement of the needle
and syrine with the patient standin followed by elevation of the le, in/ection of the
aent, and bandae compression of the area for # to B wees. +odium chloride #B.3J
is the aent most prefer, but a wide selection is available. 9urrent indications for
sclerotherapy include superficial venules !H$ mm&, varicosities $ to B mm in diameter,
postoperative residual veins, small conenital vascular malformations of venous
predominance, bleedin varices, and lare varices around an ulcer. 'he most commoncomplications include hyperpimentation, sin necrosis, pain, anaphylaxis, and
mattin.
'he oals of operative treatment are the elimination of the hydrostatic forces of
saphenous reflux, the removal the hydrodynamic forces of perforatin vein reflux, and
the eradication of the varicosities in as cosmetic a manner as possible. 5ach case must
be planned thorouhly because routine strippin of the reater saphenous vein from
roin to anle usually is not reAuired. *atients with saphenous reflux should have
roin%to%nee strippin. -t is unnecessary to strip the below%the%nee portion of the
vein unless it is varicose. +tab avulsion of vein clusters, which are mared
preoperatively, supplements the strippin.
Removal of the reater saphenous vein reAuires its detachment from the common
femoral vein and liation of its tributaries at the saphenofemoral /unction !"i. #$%#1&.
-f an anle incision is made, care must be taen to avoid in/ury to the saphenous
nerve. 8leedin can be reduced by the use of a tourniAuet and le elevation durin the
strippin. 'he incisions made for stab avulsion of varices are $ to # mm in lenth and
are oriented in the sin lines. 5cchymosis is the most common complication after
operations for varicose veins. 'he incidence can be reduced by carefully placed
elastic support. Recurrences are usually due to incompetence at the roin or in the
midthih from perforatin veins.
Ch$onic Venous !nsu%%iciency
9hronic venous insufficiency or the postthrombotic syndrome develops in
approximately (1 percent of the patients with deep venous thrombosis. -t is estimated
that there are (11,111 patients in the Enited +tates with venous ulcers. )omans noted
in $=$D that ?overstretchin of the vein walls and destruction of the valves upon
which the mechanism principally depends brin about a deree of surface stasis which
obviously interferes with the nutrition of the sin and subcutaneous tissues.@ -t is now
nown that recanali6ation of the deep veins results in valvular incompetence, which in
turn results in a lon column of blood that transmits pressures of over $11 mm) to
the venules, causin the development of abnormal capillaries. 'hese new vessels havean increased permeability to fibrinoen and red blood cells. Lymphocyte and
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 21/29
macrophae recruitment occurs in response to extravasated protein. *ericapillary
cuffin, an attempt by the endothelial cells to limit extravasation, occurs and results in
widened endothelial ap /unctions. 'he result is thicenin and lipodermatosclerosis
of the subcutaneous tissues that produce a characteristic ?brawny@ edema. 'he loss of
red cells results in hemosiderin deposits, producin the characteristic pimentation. 7
deterioration of mononuclear cell function is associated with chronic venousinsufficiency. 7 decreased capacity for lymphocyte and monocyte proliferation in
response to various challenes translates into poor or proloned wound healin. ;hen
the distal perforatin veins become incompetent, there is additional pressure, with
sin atrophy leadin ultimately to necrosis and chronic stasis ulceration !"i. #$%#$&.
Dia#nosis
'he dianosis of chronic venous insufficiency usually is made by inspectin the le.
*hysical findins do not provide information about the presence, extent, or location of
valvular incompetence or obstruction. >uplex scannin is the most reliable method of
identifyin valvular incompetence and venous obstruction.
enous valvular incompetence is identified easily with the duplex scanner. 'he vein
to be studied is identified with 8%mode imain. ;hile the velocity spectrum is
displayed, various maneuvers are performed to reverse the normal peripheral%to%
central radient. Retrorade flow is indicated by an inverted spectrum and a chane in
color from blue to red. Reflux is evaluated in the roin by havin the patient perform
a alsalva maneuver. 7 period of reversed flow exceedin $.( s is considered
abnormal. Manual compression is used above and below the vein in Auestion. +ome
prefer to examine the veins for reflux while the patient is standin. 7 pneumatic cuff
is placed at various levels beinnin at ( cm below the vein in Auestion. 'he velocity
spectrum is recorded continuously as the cuff is inflated and deflated. 4ormal valves
close rapidly in response to temporary flow reversal. *erforatin veins are studied
with the patient in the reversed 'rendelenbur position. *erforators are identified as
veins arisin from the superficial veins and penetratin the deep fascia into the
muscular compartment. Outward flow with calf compression indicates valvular
incompetence. enous valves are identified with 8%mode imain. 4ormal valves are
thin and mobile diseased valves are shortened and thic, often with attached
echoenic material.
enous obstruction is identified with the same techniAues used to dianosis acute
venous thrombosis. 7fter the vein is identified with 8% mode imain, its patency is
assessed by its compressibility and >oppler spectrum. ;ith partial occlusion orincomplete recanali6ation, there will be an encroachment on the flow imae that no
loner fills the entire vein. 9ollateral veins will be seen, and that findin is
particularly useful in distinuishin between acute versus chronic occlusions. 7nother
distinuishin feature of chronic occlusion is the shrunen si6e of the vein when
compared to the distention seen in acute >'.
'he physioloic response to venous reflux can be measured. 7 needle is placed in a
dorsal foot vein and secured in place. 'he patient2s venous pressures can be
determined in the restin and active state. 'he pressure in the standin position is
slihtly hiher than the hydrostatic force of a column extendin from the atrium to the
foot. Restin pressures in patients with and without venous insufficiency are similar.-n contrast to normal patients, who reduce their distal venous pressure with walin,
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 22/29
patients with the postthrombotic syndrome ain no benefit from their muscle pump
and their pressure increase !"i. #$%##&. -f there has been failure of recanali6ation
with persistent obstruction, the increase in blood flow with exercise may increase
venous hypertension to produce ischemic pain referred to as venous claudication.
Nonope$ati&e )ana#ement'he oals of treatment are to alleviate symptoms, heal ulcerations, and prevent ulcer
recurrences. 'he vast ma/ority of patients can be manaed nonoperatively. 7lthouh
the mechanism of benefit is unnown, compression therapy is the most important
aspect of patient manaement. 9onflictin hypotheses include a reduction in
ambulatory venous pressure, improvements of the microcirculation of the sin and
subcutaneous tissue, and increase in the pressure of the subcutaneous tissue that
reduces the leaae of fluid from the capillaries. 'he latter is the most plausible
because cutaneous metabolism may improve after fluid resorption, allowin an
enhanced diffusion of oxyen and other nutrients.
'he initial treatment of patients with venous ulceration should include a period ofstrict bed rest to reduce edema. +ystemic antibiotics are iven for the surroundin
cellulitis. 5lastic stocins are fitted when the edema has subsided. +urroundin areas
of dermatitis are treated with topical steroids. *atients are then instructed to wear the
elastic stocins for life. 'wo pairs are prescribed to allow for daily launderin of
alternate pairs. Elcer recurrence is $< percent in compliant patients, but lon% term
compliance is difficult to achieve with patients who are reluctant to wear the
stocins after their ulcer is healed. +ome physicians prefer the paste au6e boot !the
Enna boot& durin the ulcer healin phase. 'his dressin contains calamine, 6inc
oxide, lycerin, sorbitol, elatin, and manesium aluminum silicate. *atients whose
ulcers fail to heal after proloned outpatient care reAuire hospitali6ation.
Ope$ati&e )ana#ement
*atients selected for operation have severe, disablin symptoms and a history of
recurrent ulceration despite aressive medical therapy. 9andidates for operation
should undero ascendin and descendin venoraphy in addition to duplex scans and
ambulatory venous pressures. 'hese tests provide data allowin an individuali6ed
treatment plan that addresses specific areas of obstruction or reflux.
Pe$%o$ato$ Vein Li#ation
)ealin of chronic stasis ulcers is not liely unless the perforatin veins responsible
for the ulcer are identified and liated. 'he typical location of these veins is posteriorand superior to the medial malleolus. Liation of the perforator vessels should be the
initial procedure for recurrent ulceration. 'reatment failure occurs in $1 percent of
patients despite viorous medical therapy, includin support stocins, le elevation,
wound care, and patient education. 'hese patients should be considered for venous
reconstruction.
Venous Reconst$uction
'he present attitude of most sureons toward venous reconstruction is critical and
pessimistic. 'he venous system, unlie the arterial system, tends to recanali6e, thus
main it more difficult to Auantitate the obstruction and identify the patient who may
benefit from venous reconstruction. >ale estimated that the percentae of patients
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 23/29
with chronic venous insufficiency who could benefit from reconstruction was $ to #
percent.
*rimary valvular dysfunction can be treated by valvuloplasty. 'he valve most suitable
to direct valve repair usually is the most proximal valve in the superficial femoral
vein. 7fter >', most patients have scarred and thicened valves that do not lendthemselves to this type of reconstruction. Kistner, after studyin #11 limbs with
ascendin and descendin venoraphy, found #0 that could be treated by valve repair,
and D# percent had an excellent result. -n this procedure, floppy, incompetent valves
are tethered aainst the vein wall or shortened usin interrupted 0%1 monofilament
suture !"i. #$%#B&. Recent technical advances have allowed this procedure to be done
under direct visuali6ation usin an anioscope. Results of this procedure are difficult
to interpret because the operations are often combined with saphenous vein strippin
and perforator liation. Most investiators have reported improvement in symptoms
for proloned periods in approximately <1 to 01 percent of the patients.
>irect repair is not possible for postthrombotic valvular dysfunction. 'he tworeconi6ed options for surical candidates are transposition of a deep femoral or
saphenous vein valve or transplantation of a valve%bearin sement of the axillary
vein to the superficial femoral or popliteal vein !"i. #$%#3&. Results are not as ood
as those achieved by valvuloplasty for primary incompetence. 'aheri and coworers
described << patients with ood results in D0 percent. -n this series, B$ patients had
postoperative venorams, #0 of these were found to have valvular competence. 7
number of other investiators report symptomatic relief in (1 to =# percent and ulcer
recurrence in < to (3 percent of patients. Most of these patients had ood results
initially however, at $ year, a hih proportion of the affected limbs had reverted to
their preoperative condition. 8eran and colleaues have pointed out that for venous
valve surery to be successful, it usually must be accompanied by saphenous vein
strippin and perforator liation. 'he difficulty in identifyin patients who could
benefit from these procedures was put into perspective by >ale, who, after # years of
investiatin, failed to identify a roup of patients who would benefit from venous
valve transplantation or valvuloplasty. )usni found that venous reconstruction fails in
three situations: when the bypass raft is too small in caliber, when venous
hypertension is mild to moderate !less than 01 percent of the standin venous
pressure&, and when a thrombectomy or endophlebectomy has to be performed before
anastomosis. -n these patients who are at hih ris for failure, he has recommended a
distal arteriovenous fistula.
7pproximately one%third of patients with chronic venous insufficiency have a
predominant obstructive component because of inadeAuate recanali6ation after a
>'. *atients typically complain of swellin and pain on ambulation. 'he pain often
is described as burstin, but patients with valvular incompetence refer to their pain as
achin. 8ecause the pain of chronic venous obstruction reAuires the patient to be off
his or her feet to obtain relief, it is referred to as venous claudication. 7mbulatory
venous pressure measurements document the dianosis, and venoraphy identifies the
site of obstruction.
enous obstruction of the iliofemoral venous system can be bypassed by a saphenous
vein cross%over raft, first described by *alma and 5speron in $=(0. 'he procedureconsists of isolatin the normal contralateral saphenous vein and dividin it distally.
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 24/29
'he vein is tunneled suprapubically and anastomosed to the contralateral femoral
vein, distal to its obstruction. -n $=0# >ale described (= patients who had the *alma
bypass with excellent results in <B percent, ood results in $D percent, and a failure
rate of #1 percent. )usni, in $=0B, and +mith and 'rimble, in $=DD, reported similar
results. 'he saphenous vein cross% over raft enerally has been accepted as useful
however, the natural history of iliac vein occlusion is recanali6ation, and very few patients with iliofemoral thrombosis become candidates for surery.
Ese of the saphenous vein for popliteal%to%femoral vein bypass was described in $=(3
by ;arren and 'hayer with ood results in $1 of $3 patients. 'his operation provides
the muscle pump system a means of emptyin the calf by bypassin the occluded
superficial femoral vein. ;ith rich collateral veins in the thih, identifyin the patient
with an obstructed superficial femoral vein who miht benefit from the saphenous%to%
popliteal vein bypass is difficult. 'he saphenous vein is dissected free below the nee
and anastomosed to the popliteal vein, which is obstructed proximally. )usni has
populari6ed this procedure and has reported the outcome in #D patients with a ood
result in <B percent. >ale reported ood results in $1 patients !<1 percent&, and +mithand 'rimble, in a collected series of (= patients, reported ood results in D< percent.
'he ma/ority of iliofemoral thromboses occur on the left side. 'his is attributed to the
riht iliac artery compressin the left iliac vein as it crosses the fifth lumbar vertebra.
arious autopsy series and operative studies have documented the presence of left
iliac vein webs and scarrin in patients who have had iliofemoral thrombosis. 'here
was interest in this problem in the $=<1s by 9alnan and associates and by 9ocett and
'homas, who advocated surical correction of these lesions. >ale reviewed eiht such
patients identified by venoraphy and subseAuently operated on four, trimmin out
anterior webs or scar tissue and usin a venous patch for closure. 'wo of the patients
had excellent results edema developed later in one patient, and a fourth patient had a
complicated postoperative course, complainin of excruciatin pain and postoperative
swellin. >ale recommended operation only for the patient whose symptoms are
severe and who accepts the operation with the understandin that the results are not
predictable. +mith and 'rimble have followed B1 patients with this problem and have
operated on $3, with an 0( percent postoperative improvement rate. 9ocett and
'homas, conversely, found the results unsatisfactory, and after operatin on B1
patients usin several different methods they recommended abandonin the
procedure.
Venous T$aumaenous in/uries of the extremities usually are associated with arterial in/uries because
of their anatomic proximity. >irect liation of in/ured superficial veins is appropriate
treatment except when they are the sole remainin venous drainae of the extremity,
which mandates their repair. 'reatment of in/uries of the deep veins chaned
dramatically as a result of the military experience in Korea and ietnam, as reported
by Rich and associates. -t was well demonstrated that liation of ma/or extremity
veins resulted in hiher rates of disability and limb loss than repair or replacement by
autoenous vein sements. 'he concept of primary repair of venous in/uries by suture
vein patch or vein raft interposition has been extended to civilian in/uries by
7arwal and associates with favorable results. 'he rationale for primary repair is
based in part on the adverse hemodynamic effects in the first D# h after ma/or venousliation. 9urrent recommendations are that repair of the common femoral and
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 25/29
popliteal veins should be done whenever possible. Repair of the superficial femoral
vein is controversial.
L4)PHAT!C AND L4)PHEDE)A
Anatomy and Physio"o#y
'he exact oriin of lymphatic vessels is a matter of disareement amon
embryoloists. 'he oriinal theory of +abin traced the oriin from the venous system,
while )untinton and Mc9lure suested that lymphatics form by fusion of
mesenchymal spaces or clefts, which has been labeled the centripetal theory. 8y the
sixth wee of estation, there are paired lymph sacs in the nec and lumbar areas, and
at the eihth wee, there is a retroperitoneal lymph sac with a developin cisterna
chyli. 'hese systems develop communicatin channels that ultimately form the
thoracic duct by merer of the riht lymphatic duct with the left across the fourth to
sixth thoracic vertebrae, which then drains into the left subclavian vein. +mallerlymphatic ducts persist that drain into the riht subclavian vein.
>evelopmental arrest or abnormalities can result in primary hypoplasia or absence of
ducts and lymph nodes. 7bnormal rowth of /uular lymph sacs can produce
unilocular or multilocular lymph cysts termed cystic hyromas. 'hese cysts also may
be found in the axilla, mediastinum, retroperitoneum, or intestinal mesentery.
)yperplastic chanes may occur to produce lymphaniomas with or without other
vascular malformations.
'he function of the lymphatic system beins with lymphatic capillaries, which collect
fluid and protein from the extravascular spaces. -n addition to the protein that cannot be reabsorbed by the venules, red blood cells, bacteria, and other larer particles can
be evacuated only throuh the lymphatics. 'his permeability is facilitated by the
absence of a basement membrane beneath the lymphatic endothelial cells. 'he
lymphatic capillaries are found beneath the epidermis in the superficial dermis. 'hese
vessels drain into valved channels in the deep dermis and subdermal tissues, formin
larer channels that follow the vascular pathways superficial to the deep fascia.
7lthouh lymphatics can be found in the intermuscular fascia, they are absent in
muscles, tendon, cartilae, brain, and cornea.
Lymph is transported by afferent vessels to reional lymph nodes that vary in si6e
accordin to their function and activity. ;ithin the medullary sinuses of the node,circulatin lymphocytes are replaced and initial contact of forein material with the
immune system is made. 5fferent lymph leaves the node via hilar channels, which are
less numerous than the afferent channels that enter the convex side of the node. -n
addition to direct thoracic duct drainae into the subclavian vein, there are other
lymphovenous communications within nodes and in peripheral vessels. 9entral
lymphatic flow is promoted by the lymphatic valves, muscular contractions in larer
ducts, respiration, arterial pulsation, and external massae. 'he main function of the
lymphatic system is to clear the interstitial spaces of excess water and particulate
matter.
Lymphedema
9lassification of Lymphedema
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 26/29
'he oriinal classification of 7llen was into two types, one in which there was no
nown cause, and the other secondary to a nown disease or disorder. 'he primary
lymphedemas were called conenital when present at birth and praecox when there
was onset in childhood. Kinmonth added the term tarda for when the onset was not
until later life. ;ith the advent of lymphoraphy it became possible to classify the
primary lymphedemas structurally into hyperplasias and hypoplasias. 'he oriinalclassification as proposed by Kinmonth has larely been abandoned for the more
simplified version presented in 'able #$%<.
'he conenital lymphedemas are hypoplastic in =# percent of cases. 'heir subroups
are defined by lymphoraphy and behave differently. 'hose with distal hypoplasia
have a mild, nonproressive form of the disorder provided that their proximal
pathways are normal. Most of these patients are women and notice the onset after
puberty. -n proximal hypoplasia, the lymphedema is more extensive, involvin the
entire extremity, and it occurs eAually amon males and females. 'he combination of
proximal and distal hypoplasia shows features of both roups and tends to be
proressive.
'he primary hyperplastic lymphedemas are uncommon !0 percent&, and those with
bilateral hyperplasia usually can be reconi6ed by diffuse capillary aniomata on the
lateral sides of the feet. Lymphoraphy shows dilated lymphatics with normal valves,
in contrast to the findins in the mealymphatic roup, in which no valves can be
seen. -n this latter roup, chylous reflux may produce chylometrorrhea, sin vesicles,
or chyluria.
'he most common cause of secondary lymphedema in this country is malinant
disease metastatic to lymph nodes. +urical removal of nodes, especially when
combined with radiation therapy that produces lymphatic fibrosis, is another common
cause. -n tropical and subtropical countries, filariasis is the most common cause of
secondary lymphedema, producin the typical appearance of elephantiasis. Other
infective and chemical aents, such as silica, can enter the lymphatic system via
barefoot walin and cause fibrosis of lymphatics and lymph nodes.
9linical Manifestations
Lymphedema is a clinical dianosis and should be restricted to situations where other
causes of edema have been excluded or a specific lymphatic abnormality has been
demonstrated. 'he presence of bilateral dependent ?pittin@ edema usually indicates a
renal or cardiac etioloy. Other enerali6ed hypoproteinemias may be seen inmalnutrition, cirrhosis, and protein%losin enteropathy, or they may be idiopathic.
7lleries or hereditary causes are unusual. -n unilateral edema, venous disease is the
most liely cause and can be reconi6ed by the examinations described in the
previous section.
'he patient with lymphedema complains of swellin and fatiue. Limb si6e increases
durin the day and decreases at niht but is never normal. -t is important to determine
whether there is a family history of primary lymphedema and whether the patient has
visited any countries where filariasis is endemic. 'he presence of weiht loss and
diarrhea suests small bowel lymphaniectasia. On examination, lymphedema is
characteristically firm and rubbery but nonpittin. Lymph vesicles may be presentcontainin fluid of hih protein concentration. 9omplications of lymphedema such as
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 27/29
infection, cellulitis, erythema, and hypereratosis may be present. -t is important to
document limb si6e to identify isolated limb iantism and the Klippel%'rnaunay
syndrome that may have hypoplastic lymphatics in addition to venous abnormalities,
capillary nevus, and limb elonation. 'he patient should be examined for upper
extremity and enital lymphedema, hydroceles, and ameloenesis imperfecta.
>ianostic +tudies
>ye -n/ection
Lymphatics can be visuali6ed by dye in/ection in the extremities and mesentery, and
also by inestion of cream or mil to visuali6e intestinal lacteals and ma/or ducts.
7 hihly diffusible dye such as patent blue, introduced by )udac and McMaster, or
sy blue dye, recommended by 8utcher and )oover, can be in/ected in 1.# mL
amounts subcutaneously into each interdiital web. Massae of the sin and
movement of the /oints usually defines a networ of fine intradermal lymphatics !"i.
#$%#(&. -f the collectin vessels are obstructed or inadeAuate, the dye diffuses throuh
the dermal lymphatics to produce a marbled appearance called ?dermal bacflow.@
Lymphoraphy
'he techniAue of lymphoraphy was developed by Kinmonth, who demonstrated that
it was possible to cannulate the lymphatics visuali6ed by dye in/ection and then in/ect
contrast medium !Lipiodol&. 'his is a meticulous and tedious procedure that may
reAuire eneral anesthesia, as proposed by Kinmonth. -f the lymphatics in the foot are
not usable, it is possible to cannulate lymphatics ad/acent to roin nodes or to in/ect
the node directly. ;ith adeAuate visuali6ation, the lymphatics in the extremity will be
identified, often as parallel tracs that are of uniform si6e and bifurcate as they
proceed proximally in contrast to the venous system. 4ormally, there is some
dilatation at the level of the valves.
Radionuclide Lymphatic 9learance
Radionuclide scannin usin human serum albumin labeled with radioactive iodine or
technetium ==m colloid has been used to monitor lymphatic clearance by serial
scannin. 7lthouh the techniAue is simpler than standard lymphoraphy, it has ma/or
disadvantaes because of the ha6iness of the scan, radiation dosae, and distribution
of the radionuclide into the extracellular fluid, main calculations of clearance
dependent on le volume.
7nalysis of 'issue "luid'issue fluid or lymph can be aspirated or collected from a tube in the subcutaneous
tissues but contributes little to the dianosis of lymphedema. 9haracteristically,
lymphedema fluid has a protein content of more than $.( CdL, in contrast to that of
edema fluid from venous hypertension, which usually is less. 'he ratio of albumin to
lobulin also is hiher in lymphedema fluid than in plasma, which is helpful in the
presence of an inflammatory exudate in which the protein content is hih but the
albumin%to%lobulin ratio is normal.
Manaement
+upportive 'reatment
'here are sinificant anatomic and physioloic limitations to the treatment oflymphedema. "rom the standpoint of physioloy, the removal of fluid is not as
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 28/29
effective as in edema of other causes because of the residual protein in lymphedema.
-n addition, from an anatomic standpoint, the development of fibrosis produces
irreversible chanes in the subcutaneous tissues. 'herefore, the options are limited
and the primary ob/ectives remain for control of edema, maintenance of healthy sin,
and avoidance of the complications of cellulitis and lymphanitis.
'he initial ob/ective of control of edema can be approached by elevation and the use
of seAuential pneumatic compression boots to massae the le. 'hese treatments can
be done at home with eAuipment rented for this purpose. Once the le has reached
optimal si6e, the patient should be fitted with firm elastic stocins as described
earlier for venous insufficiency. 'he stocins should be removed at niht and the
foot of the bed elevated to maintain the pressure radient from le to riht atrium.
Massae therapy was used in the treatment of lymphedema as early as $00# and has
current advocates.
'he onset of redness, pain, and swellin usually sinifies early cellulitis or
lymphanitis, which can be reconi6ed by red streain up the le. 'he usualcausative oranism is staphylococcus or beta%hemolytic streptococcus, which must be
treated viorously, usually with intravenous antibiotics. -n the absence of treatment,
the infection may obliterate more lymphatics and produce constitutional sins of
fever, malaise, nausea, and vomitin. 7nother freAuent complication is ec6ema, which
usually will respond to hydrocortisone cream. 7ntifunal aents may be necessary,
topically and systemically, for chronic infections, particularly between the toes. -n
contrast to the stasis edema of venous insufficiency, ulceration is unusual, althouh
fissures and lymph fistulas can develop and reAuire surical excision.
'he secondary lymphedemas may lend themselves to treatment of the underlyin
disorder, such as usin diethylcarbama6ine for filariasis or appropriate antibiotics for
tuberculosis or lymphoranuloma venereum. -n rare cases of lon%standin secondary
lymphedema, such as in the arm after radical mastectomy, a lymphaniosarcoma may
develop, appearin as a raised blue or reddish nodule. +atellite tumors and early
metastases may develop if it is not reconi6ed and widely excised.
Operative 'reatment
Only $( percent of patients with primary lymphedema become candidates for
operative treatment, which usually is directed to reducin le si6e. 'he indications for
operation are related to functional rather than cosmetic improvement, because the
appearance of the extremity even after a successful procedure will still be abnormaland show extensive scarrin. 'he best results are obtained when the bul of the
extremity has severely impaired movement or when there have been recurrent attacs
of cellulitis. 7lthouh some efforts have been made to develop techniAues to improve
lymphatic drainae, most of the established procedures consist of excisional
operations.
'hree of the excisional procedures were based on the incorrect assumption that the
deep fascia acted as a barrier to lymphatic drainae, and the efforts of Kondoleon and
associates to excise fascia or insert a dermal flap into muscle proved ineffective in
improvin lymphatic drainae. 'he oriinal procedure devised by 9harles consistin
of wide excision of lymphedematous tissue followed by sin raftin still is usefulwhen the overlyin sin is in poor condition, as in elephantiasis. 'he procedure used
8/13/2019 Chapter 21 Venous & Lymphatic
http://slidepdf.com/reader/full/chapter-21-venous-lymphatic 29/29
most often, however, is Kinmonth2s modification of )omans2s procedure, in which
sin flaps are raised to allow excision of the underlyin subcutaneous tissues.
'he most loical, albeit technically demandin, approach has been directed to
establishin lymphaticovenous anastomoses. -nitial efforts in this area were made by
4ielubowic6 and Ols6ewsi, who divided a lymph node, removed the pulp undermanification, and sutured the node capsule with its afferent lymphatics into a vein.
'his procedure is more suitable for secondary lymphedema than primary, in which the
disorder lies in the lymphatic channels themselves. 7nother promisin techniAue of
direct lymphovenous connection was developed by 9ordeiro and modified by >eni,
who used a special needle for insertion of lymphatic vessels directly into veins and
fixed them there by a sinle suture. Esin this techniAue, "ox and associates treated
eiht secondary and $# primary lymphedema patients, with follow%up as lon as 3
years. Good results were obtained in two of four postmastectomy lymphedemas, with
poor results in the other two, who had postoperative lymphanitis. 4ine of $$ patients
with primary lymphedemas had ood functional results, allowin them to resume
normal activity. 'he authors recommend lon%term preoperative anti%inflammatoryand antimicrobial therapy to avoid postoperative lymphanitis.
-t is difficult to evaluate the results of such procedures when combined with
resectional operations and in the absence of postoperative lymphoraphy to
demonstrate patency of the anastomoses. )owever, the deleterious effects of
lymphanioraphic contrast on lymphatics were well demonstrated by O28rien and
associates, who measured limb volume after lymphanioraphy in $11 patients and
found that B# percent had a sinificant increase in le volume and $= percent
developed lymphanitis. 'herefore, it seems advisable to use lymphanioraphy only
for dianostic studies and not for pre% or postoperative evaluation until safer contrast
material becomes available. 7dditional efforts to combine resectional operations with
microlymphovenous anastomoses as reported by O28rien and +hafiroff may offer
some brihter prospects for improvement of these debilitatin disorders.
!8iblioraphy omitted in *alm version&
8ac to 9ontents